Alkem Laboratories Limited Financial Ratios
ALKEM · Healthcare · Current price ₹5,050
P/E ratio
26.2x
P/B ratio
4.4x
ROE
16.7%
ROCE
19.1%
Debt / Equity
0.15
Dividend yield
1.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 26.2x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 4.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 16.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 19.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.15 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Alkem Laboratories Limited's latest numbers.
Alkem Laboratories Limited profitability
Alkem Laboratories Limited generates a return on equity of 16.7% and a return on capital employed of 19.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.15 and a P/E of 26.2x, Alkem Laboratories Limited is conservatively financed. Our overall business-quality score for the company is 5.8 / 10.
Understand the ratios
More on Alkem Laboratories Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.